2022 Sickle Cell Disease: What's New with Transplant and Gene Therapy?

Thursday, March 24, 2022, 9:00 AM - 4:00 PM, Virtual

Symposium discussing hematopoietic stem cell transplantation and gene therapy for sickle cell disease. This symposium will focus on topics such as: understanding new technologies related to HSCT/GT research, multidisciplinary collaborations among HSCT/GT experts, and the importance of including patients in the process of HSCT/GT research.

1. Identify possible areas of collaboration and potential collaborators in HSCT and GT research.
2. Describe multidisciplinary areas of need in new protocols and identify the types of experts who should be included to address them.
3. Implement strategies to encourage SCD patient involvement in HSCT/GT research protocols.

Registration is free, but preregistration is required.

Registration is now closed. 

If you have any questions about this symposium, please contact Jane Stringellow at [email protected] or 901-595-6076.

Supported by the Doris Duke Charitable Foundation.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of St. Jude Children's Research Hospital, the Doris Duke Charitable Foundation, and Mattel Children's Hospital. St. Jude Children's Research Hospital is accredited by the ACCME to provide continuing medical education for physicians.

St. Jude Children’s Research Hospital designates this Live Activity for a maximum of 4.50 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (4.50 hours), Non-Physician Attendance (4.50 hours)

The faculty for this activity are listed below. Click to view the faculty member's financial disclosure information and bio. 

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Thursday, March 24, 2022